ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is a pathological term used to identify invasive breast cancers that lack the expression of estrogen and progesterone receptors (ER/PR) and do not harbor pathologic overexpression of the human epidermal growth factor receptor 2 (HER2) or amplification of the ERBB2 gene.